CYCN
$1.59+0.08 (+5.30%)
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.
Recent News
BC-Most Active Stocks
HIVE Digital Technologies Ltd. 18,936,738 3.09
Akebia Therapeutics Sets Rare Kidney Drug Plan After Q32 Bio Deal
Akebia Therapeutics (AKBA) said Monday that it has built a rare kidney disease pipeline around a com
Insider Stock Buying Reaches US$525.0k On Cyclerion Therapeutics
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network
Cybersecurity and IT services company Cycurion, Inc. (NASDAQ:CYCU) announced Monday that it has bagged a contract with a leading telecommunications company to deliver network deployment services supporting a critical modernization initiative for one of the federal government's largest agencies. The rollout encompasses more than 1,300 sites across all 50 states and U.S. territories, with an expected duration of 24 to 36 months and a potential total value exceeding $1 million. The multi-year proje